Unique ID issued by UMIN | UMIN000033751 |
---|---|
Receipt number | R000038496 |
Scientific Title | Procedure of risk rducing surgery for hereditary gynecologic tumor |
Date of disclosure of the study information | 2018/10/01 |
Last modified on | 2020/03/20 21:00:43 |
Procedure of risk rducing surgery for hereditary gynecologic tumor
RRSO
Procedure of risk rducing surgery for hereditary gynecologic tumor
RRSO
Japan |
BRCA1, BRCA2,MLH1,MSH2,MSH6,PMS2,BRIP1,RAD51C or RAD51D mutation carriers
Hematology and clinical oncology | Obstetrics and Gynecology |
Malignancy
YES
Critical prevention of ovarian, fallopian tubal and peritoneal cancer in hereditary tumor-related gene carrires by RRSO
Efficacy
Incidence rate of ovarian, fallopian tubal and peritoneal cancer
Interventional
Single arm
Non-randomized
Open -no one is blinded
Uncontrolled
1
Prevention
Maneuver |
Risk reducing salpingo-oophorectomy
20 | years-old | <= |
45 | years-old | > |
Female
BRCA1, BRCA2,MLH1,MSH2,MSH6,PMS2,BRIP1,RAD51C or RAD51D mutation carrier
Woman affected a gynecology cancer
30
1st name | |
Middle name | |
Last name | Watanabe Takafumi |
Fukushima Medical University
Obstetrics and Gynecology
1 Hikariga-oka, Fukushima City 960-1295, JAPAN
024-547-1290
t-wata@fmu.ac.jp
1st name | |
Middle name | |
Last name | Watanabe Takafumi |
Fukushima Medical University
Obstetrics and Gynecology
1 Hikariga-oka, Fukushima City 960-1295, JAPAN
024-547-1290
t-wata@fmu.ac.jp
Fukushima Medical University
No
Other
NO
2018 | Year | 10 | Month | 01 | Day |
Unpublished
Terminated
2018 | Year | 10 | Month | 01 | Day |
2020 | Year | 06 | Month | 14 | Day |
2018 | Year | 11 | Month | 01 | Day |
2022 | Year | 03 | Month | 31 | Day |
2018 | Year | 08 | Month | 14 | Day |
2020 | Year | 03 | Month | 20 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000038496